|
Back to products
Browse products
Approved anticancer agents
Anticancer agents in trials
Anticancer agents
in preclinical trials
Anticancer molecular libraries
Other drug agents
Drug intermediates
Bio-reagents and biochemicals
|
MedKoo Product Information:
Hesperadin
|
MedKoo Code#: 201466
|
|
Name: Hesperadin
|
|
CAS#: 422513-13-1
Synonym:
Hesperadin
IUPAC/Chemical name:
(Z)-N-(2-oxo-3-(phenyl((4-(piperidin-1-ylmethyl)phenyl)amino)methylene)indolin-5-yl)ethanesulfonamide
|
|
Chemical structure
|
Theoretical analysis
|
|

|
Chemical Formula: C29H32N4O3S
Exact Mass: 516.21951
Molecular Weight: 516.65
m/z: 516.21951 (100.0%), 517.22287 (31.4%),
518.22622 (4.7%), 518.21531 (4.5%), 517.21655 (1.5%), 519.21866
(1.4%)
Elemental Analysis: C, 67.42; H, 6.24; N,
10.84; O, 9.29; S, 6.21
|
|
Availability and price:
This product is available.
To inquire quotation or to ask questions, please send email to
sales@medkoo.com to describe your needs. A representative
will respond your email shortly. We offer big discount for orders of bulk quantities.
|
|
Information about this agent
|
Hesperadin, an inhibitor of human Aurora B, prevented
the phosphorylation of substrate with IC(50) of 40 nM. Growth of
cultured bloodstream forms was also sensitive to Hesperadin (IC(50) of
50 nM). Hesperadin blocked nuclear division and cytokinesis but not
other aspects of the cell cycle. Consequently, growth arrested cells
accumulated multiple kinetoplasts, flagella and nucleoli, similar to the
effects of RNAi-dependent knockdown of TbAUK1 in cultured bloodstream
forms cells. Molecular models predicted high-affinity binding of
Hesperadin to both conserved and novel sites in TbAUK1. Collectively,
these data demonstrate that cell cycle progression is essential for
infections with T. brucei and that parasite Aurora kinases can be
targeted with small-molecule inhibitors. [See:
Mol Microbiol. 2009 Apr;72(2):442-58. Epub 2009 Mar 6. or
http://www.ncbi.nlm.nih.gov/pubmed/19320832] .
1: Keerthivasan G, Small S, Liu H, Wickrema A,
Crispino JD. Vesicle trafficking plays a novel role in erythroblast
enucleation. Blood. 2010 Oct 28;116(17):3331-40. Epub 2010 Jul 19.
PubMed PMID: 20644112; PubMed Central PMCID: PMC2995360.
2: Hall LL, Byron M, Pageau G, Lawrence JB. AURKB-mediated effects on
chromatin regulate binding versus release of XIST RNA to the inactive
chromosome. J Cell Biol. 2009 Aug 24;186(4):491-507. PubMed PMID:
19704020; PubMed Central PMCID: PMC2733744.
3: Demidov D, Hesse S, Tewes A, Rutten T, Fuchs J, Ashtiyani RK, Lein S,
Fischer A, Reuter G, Houben A. Aurora1 phosphorylation activity on
histone H3 and its cross-talk with other post-translational histone
modifications in Arabidopsis. Plant J. 2009 Jul;59(2):221-30. PubMed
PMID: 19582900.
4: Hivert V, Pierre J, Raingeaud J. Phosphorylation of human enhancer of
filamentation (HEF1) on serine 369 induces its proteasomal degradation.
Biochem Pharmacol. 2009 Oct 15;78(8):1017-25. Epub 2009 Jun 17. PubMed
PMID: 19539609.
5: Jetton N, Rothberg KG, Hubbard JG, Wise J, Li Y, Ball HL, Ruben L.
The cell cycle as a therapeutic target against Trypanosoma brucei:
Hesperadin inhibits Aurora kinase-1 and blocks mitotic progression in
bloodstream forms. Mol Microbiol. 2009 Apr;72(2):442-58. Epub 2009 Mar
6. PubMed PMID: 19320832; PubMed Central PMCID: PMC2697958.
6: Dreier MR, Grabovich AZ, Katusin JD, Taylor WR. Short and long-term
tumor cell responses to Aurora kinase inhibitors. Exp Cell Res. 2009 Apr
15;315(7):1085-99. Epub 2009 Feb 20. PubMed PMID: 19233169.
7: Yeh MH, Kao ST, Hung CM, Liu CJ, Lee KH, Yeh CC. Hesperidin inhibited
acetaldehyde-induced matrix metalloproteinase-9 gene expression in human
hepatocellular carcinoma cells. Toxicol Lett. 2009 Feb 10;184(3):204-10.
Epub 2008 Dec 6. PubMed PMID: 19110045.
8: O'Connell CB, Loncarek J, Hergert P, Kourtidis A, Conklin DS,
Khodjakov A. The spindle assembly checkpoint is satisfied in the absence
of interkinetochore tension during mitosis with unreplicated genomes. J
Cell Biol. 2008 Oct 6;183(1):29-36. Epub 2008 Sep 29. PubMed PMID:
18824563; PubMed Central PMCID: PMC2557037.
9: Wang W, Stukenberg PT, Brautigan DL. Phosphatase inhibitor-2 balances
protein phosphatase 1 and aurora B kinase for chromosome segregation and
cytokinesis in human retinal epithelial cells. Mol Biol Cell. 2008
Nov;19(11):4852-62. Epub 2008 Aug 20. PubMed PMID: 18716057; PubMed
Central PMCID: PMC2575180.
10: Kurihara D, Matsunaga S, Uchiyama S, Fukui K. Live cell imaging
reveals plant aurora kinase has dual roles during mitosis. Plant Cell
Physiol. 2008 Aug;49(8):1256-61. Epub 2008 Jul 1. PubMed PMID: 18593743.
11: Talele TT, McLaughlin ML. Molecular docking/dynamics studies of
Aurora A kinase inhibitors. J Mol Graph Model. 2008 Jun;26(8):1213-22.
Epub 2007 Nov 17. PubMed PMID: 18096419.
12: Agnese V, Bazan V, Fiorentino FP, Fanale D, Badalamenti G, Colucci
G, Adamo V, Santini D, Russo A. The role of Aurora-A inhibitors in
cancer therapy. Ann Oncol. 2007 Jun;18 Suppl 6:vi47-52. Review. PubMed
PMID: 17591831.
13: Miyauchi K, Zhu X, Foong C, Hosoya H, Murata-Hori M. Aurora B kinase
activity is required to prevent polar cortical ingression during
cytokinesis. Cell Cycle. 2007 Oct 15;6(20):2549-53. Epub 2007 Jul 31.
PubMed PMID: 17726378.
14: McEvoy M, Cao G, Montero Llopis P, Kundel M, Jones K, Hofler C, Shin
C, Wells DG. Cytoplasmic polyadenylation element binding protein
1-mediated mRNA translation in Purkinje neurons is required for
cerebellar long-term depression and motor coordination. J Neurosci. 2007
Jun 13;27(24):6400-11. PubMed PMID: 17567800.
15: Lipp JJ, Hirota T, Poser I, Peters JM. Aurora B controls the
association of condensin I but not condensin II with mitotic
chromosomes. J Cell Sci. 2007 Apr 1;120(Pt 7):1245-55. Epub 2007 Mar 13.
PubMed PMID: 17356064.
16: Sakita-Suto S, Kanda A, Suzuki F, Sato S, Takata T, Tatsuka M.
Aurora-B regulates RNA methyltransferase NSUN2. Mol Biol Cell. 2007
Mar;18(3):1107-17. Epub 2007 Jan 10. PubMed PMID: 17215513; PubMed
Central PMCID: PMC1805108.
17: Kurihara D, Matsunaga S, Kawabe A, Fujimoto S, Noda M, Uchiyama S,
Fukui K. Aurora kinase is required for chromosome segregation in tobacco
BY-2 cells. Plant J. 2006 Nov;48(4):572-80. PubMed PMID: 17087760.
18: Kapoor TM, Lampson MA, Hergert P, Cameron L, Cimini D, Salmon ED,
McEwen BF, Khodjakov A. Chromosomes can congress to the metaphase plate
before biorientation. Science. 2006 Jan 20;311(5759):388-91. PubMed
PMID: 16424343.
19: Kubo M, Matsuda H, Tomohiro N, Harima S. [History and therapeutic
evaluation of Citrus hassaku HORT. Tanaka]. Yakushigaku Zasshi.
2004;39(2):363-4. Japanese. PubMed PMID: 16025659.
20: Ladygina NG, Latsis RV, Yen T. [Effect of the pharmacological agent
hesperadin on breast and prostate tumor cultured cells]. Biomed Khim.
2005 Mar-Apr;51(2):170-6. Russian. PubMed PMID: 15945350.
21: Yang H, Burke T, Dempsey J, Diaz B, Collins E, Toth J, Beckmann R,
Ye X. Mitotic requirement for aurora A kinase is bypassed in the absence
of aurora B kinase. FEBS Lett. 2005 Jun 20;579(16):3385-91. PubMed PMID:
15922328.
22: Sessa F, Mapelli M, Ciferri C, Tarricone C, Areces LB, Schneider TR,
Stukenberg PT, Musacchio A. Mechanism of Aurora B activation by INCENP
and inhibition by hesperadin. Mol Cell. 2005 Apr 29;18(3):379-91. PubMed
PMID: 15866179.
23: Sumara I, Giménez-Abián JF, Gerlich D, Hirota T, Kraft C, de la
Torre C, Ellenberg J, Peters JM. Roles of polo-like kinase 1 in the
assembly of functional mitotic spindles. Curr Biol. 2004 Oct
5;14(19):1712-22. PubMed PMID: 15458642.
24: Doggrell SA. Dawn of Aurora kinase inhibitors as anticancer drugs.
Expert Opin Investig Drugs. 2004 Sep;13(9):1199-201. Review. PubMed
PMID: 15330750.
25: Hauf S, Cole RW, LaTerra S, Zimmer C, Schnapp G, Walter R, Heckel A,
van Meel J, Rieder CL, Peters JM. The small molecule Hesperadin reveals
a role for Aurora B in correcting kinetochore-microtubule attachment and
in maintaining the spindle assembly checkpoint. J Cell Biol. 2003 Apr
28;161(2):281-94. Epub 2003 Apr 21. PubMed PMID: 12707311; PubMed
Central PMCID: PMC2172906.
|
Contact MedKoo:
Email:
sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|